This report contains market size and forecasts of Xerostomia (Dry Mouth) Therapeutics in global, including the following market information:
Global Xerostomia (Dry Mouth) Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Xerostomia (Dry Mouth) Therapeutics Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Xerostomia (Dry Mouth) Therapeutics companies in 2020 (%)
The global Xerostomia (Dry Mouth) Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Xerostomia (Dry Mouth) Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Xerostomia (Dry Mouth) Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Xerostomia (Dry Mouth) Therapeutics Market Segment Percentages, By Type, 2020 (%)
Salivary Stimulants
Salivary Substitutes
Dentifrices
Global Xerostomia (Dry Mouth) Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Xerostomia (Dry Mouth) Therapeutics Market Segment Percentages, By Application, 2020 (%)
OTC
Prescription
Global Xerostomia (Dry Mouth) Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Xerostomia (Dry Mouth) Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Xerostomia (Dry Mouth) Therapeutics revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Xerostomia (Dry Mouth) Therapeutics revenues share in global market, 2020 (%)
Key companies Xerostomia (Dry Mouth) Therapeutics sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Xerostomia (Dry Mouth) Therapeutics sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc
Church & Dwight, Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Xerostomia (Dry Mouth) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Xerostomia (Dry Mouth) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Xerostomia (Dry Mouth) Therapeutics Overall Market Size
2.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size: 2021 VS 2027
2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Xerostomia (Dry Mouth) Therapeutics Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Xerostomia (Dry Mouth) Therapeutics Players in Global Market
3.2 Top Global Xerostomia (Dry Mouth) Therapeutics Companies Ranked by Revenue
3.3 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Companies
3.4 Global Xerostomia (Dry Mouth) Therapeutics Sales by Companies
3.5 Global Xerostomia (Dry Mouth) Therapeutics Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Xerostomia (Dry Mouth) Therapeutics Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Xerostomia (Dry Mouth) Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Xerostomia (Dry Mouth) Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Xerostomia (Dry Mouth) Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Xerostomia (Dry Mouth) Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Salivary Stimulants
4.1.3 Salivary Substitutes
4.1.4 Dentifrices
4.2 By Type - Global Xerostomia (Dry Mouth) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Xerostomia (Dry Mouth) Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Xerostomia (Dry Mouth) Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share, 2016-2027
4.3 By Type - Global Xerostomia (Dry Mouth) Therapeutics Sales & Forecasts
4.3.1 By Type - Global Xerostomia (Dry Mouth) Therapeutics Sales, 2016-2021
4.3.2 By Type - Global Xerostomia (Dry Mouth) Therapeutics Sales, 2022-2027
4.3.3 By Type - Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share, 2016-2027
4.4 By Type - Global Xerostomia (Dry Mouth) Therapeutics Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Xerostomia (Dry Mouth) Therapeutics Market Size, 2021 & 2027
5.1.2 OTC
5.1.3 Prescription
5.2 By Application - Global Xerostomia (Dry Mouth) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Xerostomia (Dry Mouth) Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Xerostomia (Dry Mouth) Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share, 2016-2027
5.3 By Application - Global Xerostomia (Dry Mouth) Therapeutics Sales & Forecasts
5.3.1 By Application - Global Xerostomia (Dry Mouth) Therapeutics Sales, 2016-2021
5.3.2 By Application - Global Xerostomia (Dry Mouth) Therapeutics Sales, 2022-2027
5.3.3 By Application - Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share, 2016-2027
5.4 By Application - Global Xerostomia (Dry Mouth) Therapeutics Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Xerostomia (Dry Mouth) Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Xerostomia (Dry Mouth) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Xerostomia (Dry Mouth) Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Xerostomia (Dry Mouth) Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share, 2016-2027
6.3 By Region - Global Xerostomia (Dry Mouth) Therapeutics Sales & Forecasts
6.3.1 By Region - Global Xerostomia (Dry Mouth) Therapeutics Sales, 2016-2021
6.3.2 By Region - Global Xerostomia (Dry Mouth) Therapeutics Sales, 2022-2027
6.3.3 By Region - Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Xerostomia (Dry Mouth) Therapeutics Revenue, 2016-2027
6.4.2 By Country - North America Xerostomia (Dry Mouth) Therapeutics Sales, 2016-2027
6.4.3 US Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.4.4 Canada Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.4.5 Mexico Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Xerostomia (Dry Mouth) Therapeutics Revenue, 2016-2027
6.5.2 By Country - Europe Xerostomia (Dry Mouth) Therapeutics Sales, 2016-2027
6.5.3 Germany Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.5.4 France Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.5.5 U.K. Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.5.6 Italy Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.5.7 Russia Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.5.8 Nordic Countries Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.5.9 Benelux Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Xerostomia (Dry Mouth) Therapeutics Revenue, 2016-2027
6.6.2 By Region - Asia Xerostomia (Dry Mouth) Therapeutics Sales, 2016-2027
6.6.3 China Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.6.4 Japan Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.6.5 South Korea Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.6.6 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.6.7 India Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Xerostomia (Dry Mouth) Therapeutics Revenue, 2016-2027
6.7.2 By Country - South America Xerostomia (Dry Mouth) Therapeutics Sales, 2016-2027
6.7.3 Brazil Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.7.4 Argentina Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales, 2016-2027
6.8.3 Turkey Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.8.4 Israel Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.8.5 Saudi Arabia Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
6.8.6 UAE Xerostomia (Dry Mouth) Therapeutics Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Corporate Summary
7.1.2 GlaxoSmithKline plc Business Overview
7.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.1.5 GlaxoSmithKline plc Key News
7.2 Church & Dwight, Inc.
7.2.1 Church & Dwight, Inc. Corporate Summary
7.2.2 Church & Dwight, Inc. Business Overview
7.2.3 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.2.4 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.2.5 Church & Dwight, Inc. Key News
7.3 Colgate-Palmolive Company
7.3.1 Colgate-Palmolive Company Corporate Summary
7.3.2 Colgate-Palmolive Company Business Overview
7.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.3.4 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.3.5 Colgate-Palmolive Company Key News
7.4 Hikma Pharmaceuticals PLC
7.4.1 Hikma Pharmaceuticals PLC Corporate Summary
7.4.2 Hikma Pharmaceuticals PLC Business Overview
7.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.4.4 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.4.5 Hikma Pharmaceuticals PLC Key News
7.5 Pendopharm
7.5.1 Pendopharm Corporate Summary
7.5.2 Pendopharm Business Overview
7.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.5.4 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.5.5 Pendopharm Key News
7.6 Sun Pharmaceuticals Industries Ltd.
7.6.1 Sun Pharmaceuticals Industries Ltd. Corporate Summary
7.6.2 Sun Pharmaceuticals Industries Ltd. Business Overview
7.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.6.5 Sun Pharmaceuticals Industries Ltd. Key News
7.7 Lupin Pharmaceuticals, Inc.
7.7.1 Lupin Pharmaceuticals, Inc. Corporate Summary
7.7.2 Lupin Pharmaceuticals, Inc. Business Overview
7.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.4.4 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.7.5 Lupin Pharmaceuticals, Inc. Key News
7.8 Pfizer, Inc.
7.8.1 Pfizer, Inc. Corporate Summary
7.8.2 Pfizer, Inc. Business Overview
7.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.8.4 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.8.5 Pfizer, Inc. Key News
7.9 Parnell Pharmaceuticals, Inc.
7.9.1 Parnell Pharmaceuticals, Inc. Corporate Summary
7.9.2 Parnell Pharmaceuticals, Inc. Business Overview
7.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.9.4 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.9.5 Parnell Pharmaceuticals, Inc. Key News
7.10 Acacia Pharma
7.10.1 Acacia Pharma Corporate Summary
7.10.2 Acacia Pharma Business Overview
7.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.10.4 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.10.5 Acacia Pharma Key News
7.11 OraCoat
7.11.1 OraCoat Corporate Summary
7.11.2 OraCoat Xerostomia (Dry Mouth) Therapeutics Business Overview
7.11.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Major Product Offerings
7.11.4 OraCoat Xerostomia (Dry Mouth) Therapeutics Sales and Revenue in Global (2016-2021)
7.11.5 OraCoat Key News
8 Global Xerostomia (Dry Mouth) Therapeutics Production Capacity, Analysis
8.1 Global Xerostomia (Dry Mouth) Therapeutics Production Capacity, 2016-2027
8.2 Xerostomia (Dry Mouth) Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Xerostomia (Dry Mouth) Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Xerostomia (Dry Mouth) Therapeutics Supply Chain Analysis
10.1 Xerostomia (Dry Mouth) Therapeutics Industry Value Chain
10.2 Xerostomia (Dry Mouth) Therapeutics Upstream Market
10.3 Xerostomia (Dry Mouth) Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Xerostomia (Dry Mouth) Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Xerostomia (Dry Mouth) Therapeutics in Global Market
Table 2. Top Xerostomia (Dry Mouth) Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Companies, 2016-2021
Table 5. Global Xerostomia (Dry Mouth) Therapeutics Sales by Companies, (K MT), 2016-2021
Table 6. Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Type
Table 9. List of Global Tier 1 Xerostomia (Dry Mouth) Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Xerostomia (Dry Mouth) Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
GlaxoSmithKline plc
Church & Dwight, Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat